Yet one major bottleneck remains: obtaining timely cardiac imaging information that can help guide management decisions. A ...

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active ...

A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in ...

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia ...

In most patients with mild-to-moderate cholangitis, performing ERCP within 24-48 hours appears to be as effective as ...

With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...

Even with some grants restored, researchers say the deeper damage is harder to undo — and a proposed federal rule could make nonscientific control of science permanent.

From personal experiences to injury to patient success stories, exercise never figured prominently in these doctors’ practice ...

The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal ...

A novel knee distraction technique is drawing interest for severe osteoarthritis, with studies showing lasting symptom relief ...

The diagnostic challenge is that many patients with OSA do not present with the classic symptoms clinicians often associate ...

Patients with both asthma and diabetes have more adverse cardiometabolic and inflammatory biomarker profiles than those with neither condition, a cross-sectional study shows.